IOLC 2025: A Human-Centered Finale at the Champalimaud Foundation

Day 3 of the 9th International Oncology Leadership Conference in Lisbon delivered a powerful reminder of what truly drives progress in cancer care: people. Hosted at the iconic Champalimaud Foundation, the final sessions highlighted why innovation in oncology must remain deeply human – whether through advances in psycho-oncological support or by recognizing the essential yet often overlooked role of pharmacists in integrated cancer treatment.

Across all discussions, one message stood out clearly: meaningful impact requires global collaboration, equitable access, and a commitment to bringing science into real-world practice. With the Atlantic coastline just outside the conference walls, the atmosphere underscored the urgency and responsibility that come with shaping the future of cancer care.

Together with our partner EHMET Health, we continue to demonstrate what becomes possible when administrators, clinicians, and engineers work in a shared language – creating pathways toward more connected, accessible, and patient-centered oncology solutions.